HRES 392119th CongressIn Committee

Expressing support for the designation of May as "National Bladder Cancer Awareness Month".

Introduced: May 6, 2025

Standard Summary

Comprehensive overview in 1-2 paragraphs

H. Res. 392 is a non-binding House resolution that expresses congressional support for designating May as “National Bladder Cancer Awareness Month.” While it does not create new policy or authorize spending, the resolution frames bladder cancer as a significant public health issue—highlighting the number of people affected, the importance of early detection for better outcomes, and the need for awareness, education, and research. It also calls on the public, advocacy groups, the research community, and those affected to promote awareness, engage in the fight against bladder cancer, and observe the month with appropriate activities. The measure is introductory in the 119th Congress and referred to the Committee on Energy and Commerce.

Key Points

1Non-binding status: The resolution expresses support for designating May as National Bladder Cancer Awareness Month and for the goals of such a designation; it does not establish a program or authorize funding.
2Burden and context: It outlines the substantial impact of bladder cancer in the United States, including estimated diagnoses (over 84,000 in 2025), deaths (more than 17,000), and the fact that bladder cancer is a common cancer with particular relevance to veterans.
3Emphasis on early detection: The text stresses that early diagnosis greatly improves survivability and that awareness of symptoms (e.g., blood in urine) can lead to earlier testing and treatment.
4Risk factors and groups at higher risk: It notes smoking and exposure to carcinogenic chemicals as major causes, with higher reported incidence among firefighters, veterans, and older adults; it also highlights gender differences in diagnosis and prognosis.
5Call to action for awareness and engagement: The resolution invites individuals, groups, the research community, and affected persons to promote awareness, actively participate in efforts to end bladder cancer, and observe National Bladder Cancer Awareness Month with ceremonies and activities. It also references ongoing research funding and veteran health considerations in related contexts.

Impact Areas

Primary group/area affected- Bladder cancer patients and their families, caregivers, and communities; general public health and awareness efforts.Secondary group/area affected- Healthcare providers, researchers, patient advocacy organizations (e.g., Bladder Cancer Advocacy Network), and organizations involved in cancer screening and education.- Veterans and military/VA health programs, given references to toxin exposure and related health considerations.Additional impacts- Heightened public awareness could influence community events, fundraising, and collaboration between federal research programs (e.g., Congressionally Directed Medical Research Programs and NIH) to support bladder cancer research.- The resolution signals congressional interest in veteran health issues related to bladder cancer and may align with broader efforts to increase diagnosis, treatment options, and surveillance for bladder cancer patients.- No new statutory duties or funding commitments are created by this resolution; any concrete policy or financing would require separate legislation.

Generated by gpt-5-nano on Oct 31, 2025